Lyphe Australia Brand Profile

Lyphe Group is a patient-centred medicinal cannabis access company, dedicated to bringing medical cannabis treatments to patients with unmet clinical needs. At Lyphe Group we believe all patients with unmet clinical needs should be able to access medicinal cannabis. Lead by the experts, guided by science and dedicated to improving people’s lives, The Lyphe Group is trusted by regulators, Governments, the public and our partners to open up access to medical cannabis for patients across the world.
Lyphe Australia

Lyphe Australia Product List

Swipe left on table to view more detail.
Form Product Name Size THC CBD # of Reviews Rating Price
Alleve CBD100+ 30ml 0mg/ml 100mg/ml 0 Sign In Sign In
Alleve Balance10 30ml 10mg/ml 10mg/ml 0 Sign In Sign In
Alleve Balance25 30ml 25mg/ml 25mg/ml 2 Sign In Sign In
Alleve T26 30ml 26mg/ml <1mg/ml 0 Sign In Sign In
Aelleve WF Balance10:15 MH 10g 10% 15% 5 Sign In Sign In
Aelleve WF THC20 LL 10g 20% <1% 1 Sign In Sign In
Aelleve WF THC24 BL 10g 24% <1% 2 Sign In Sign In
Aelleve WF THC24 GTH 10g 24% <1% 2 Sign In Sign In

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. CANNABIS IS A SCHEDULED AND REGULATED DRUG.

The information above is not to be taken as medical advice. Cannabis may have negative side effects or interactions with other medications. Medical Cannabis is not effective for everyone and more research needs to be done. Please consult a health professional for advice. Canna Reviews does not receive financial incentives or compensation for displaying product information.